scispace - formally typeset
N

Niki Karavitaki

Researcher at University of Birmingham

Publications -  175
Citations -  7702

Niki Karavitaki is an academic researcher from University of Birmingham. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 40, co-authored 147 publications receiving 6071 citations. Previous affiliations of Niki Karavitaki include University Hospitals Birmingham NHS Foundation Trust & Queen Mary University of London.

Papers
More filters
Journal ArticleDOI

Prevalence of pituitary adenomas: a community‐based, cross‐sectional study in Banbury (Oxfordshire, UK)

TL;DR: The resource allocation for PAs in the health care system is lacking a reliable and an up‐to‐date epidemiological background that would reflect the recent advances in the diagnostic technologies, leading to the earlier recognition of these tumours.
Journal ArticleDOI

Hormonal replacement in hypopituitarism in adults: An endocrine society clinical practice guideline

TL;DR: Using an evidence-based approach, this guideline addresses important clinical issues regarding the evaluation and management of hypopituitarism in adults, including appropriate biochemical assessments, specific therapeutic decisions to decrease the risk of co-morbidities due to hormonal over-replacements or under-replacement, and managing hypopitsuits during pregnancy, pituitary surgery, and other types of surgeries.
Journal ArticleDOI

Craniopharyngiomas in children and adults: systematic analysis of 121 cases with long‐term follow‐up

TL;DR: This data indicates that conventional excision for Craniopharyngiomas is likely to be more effective than chemotherapy for these benign tumours, which are associated with an unfavourable prognosis and optimal treatment remains controversial.
Journal ArticleDOI

Epidemiology of acromegaly: review of population studies

TL;DR: This review systematically analysed the epidemiological profile of acromegaly based on recently published population studies from various geographical areas to reduce the adverse sequelae of late diagnosis and treatment, improve patient outcomes and, hopefully, reduce the burden on the health care system.